Amyloid beta cleavage by ANA-TA9, a synthetic peptide from the ANA/BTG3 Box A region.

Hatakawa, Yusuke; Nakamura, Rina; Konishi, Motomi; Sakane, Toshiyasu; Tanaka, Akiko; Matsuda, Akira; Saito, Motoaki; Akizawa, Toshifumi

Hatakawa, Yusuke; Nakamura, Rina; Konishi, Motomi; Sakane, Toshiyasu; Tanaka, Akiko; Matsuda, Akira; Saito, Motoaki; Akizawa, Toshifumi.

Afiliação

Hatakawa Y; Pharmaceutical Technology Kobe Pharmaceutical University Higashinada Kobe Japan.
Nakamura R; O-Force Co., Ltd Hata-gun Kochi Japan.
Konishi M; Laboratory of Pharmacology School of Medicine Kohasu Oko-cho Kochi University Nankoku Kochi Japan.
Sakane T; Department of Integrative Pharmaceutical Science Faculty of Pharmaceutical Sciences Setsunan University Hirakata Osaka Japan.
Tanaka A; Pharmaceutical Technology Kobe Pharmaceutical University Higashinada Kobe Japan.
Matsuda A; Pharmaceutical Technology Kobe Pharmaceutical University Higashinada Kobe Japan.
Saito M; Laboratory of Medicinal and Biochemical Analysis Faculty of Pharmaceutical Sciences Hiroshima International University Kure Hiroshima Japan.
Akizawa T; Laboratory of Pharmacology School of Medicine Kohasu Oko-cho Kochi University Nankoku Kochi Japan.

Alzheimers Dement (N Y) ; 7(1): e12146, 2021.

Article em En | MEDLINE | ID: mdl-33816760

Palavras-chave

ANA/BTG3; Alzheimer's disease; Aß fragment peptide; Aß42; administered nasally (i.n.); catalytide; neurodegenerative disease; serine protease; synthetic peptide

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Alzheimers Dement (N Y) Ano de publicação: 2021 Tipo de documento: Article